Amphastar Pharmaceuticals (AMPH) Change in Cash (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Change in Cash of $762000.0 for Q1 2026, down 97.56% year-over-year from $31.2 million in Q1 2025, and up 101.65% quarter-over-quarter from -$46.1 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Change in Cash (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Change in Cash history runs 14 years deep, the most recent figure standing at $762000.0 for Q1 2026.
- In Q1 2026, Change in Cash fell 97.56% year-over-year to $762000.0; the TTM figure through Mar 2026 stood at -$11.8 million (up 35.52% YoY), while the FY2025 annual figure was $18.6 million, up 153.9% from the prior year.
- Change in Cash for Q1 2026 stood at $762000.0, up from -$46.1 million in the prior quarter.
- The five-year high for Change in Cash was $119.8 million in Q3 2023, with the low at -$126.5 million in Q4 2023.
- The 5-year median for Change in Cash is $762000.0 (2026), against an average of $2.6 million.
- Peak annual rise in Change in Cash reached 1443.62% in 2023, while the deepest fall reached 10938.92% in 2023.
- Amphastar Pharmaceuticals' Change in Cash stood at -$1.1 million in 2022, then plunged by 10938.92% to -$126.5 million in 2023, then surged by 67.98% to -$40.5 million in 2024, then declined by 13.78% to -$46.1 million in 2025, then jumped by 101.65% to $762000.0 in 2026.
- Business Quant data shows AMPH's Change in Cash at $762000.0 in Q1 2026, -$46.1 million in Q4 2025, and $28.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 937.87 Mn | 647.74 Mn | 93.47 Mn | 52.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 52.68 Mn |
| Mar 31, 2026 | 762,000.00 |
| Dec 31, 2025 | -46.09 Mn |
| Sep 30, 2025 | 28.58 Mn |
| Jun 30, 2025 | 4.91 Mn |
| Mar 31, 2025 | 31.17 Mn |
| Dec 31, 2024 | -40.51 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | -11.53 Mn |
| Mar 31, 2024 | 56.85 Mn |
| Dec 31, 2023 | -126.51 Mn |
| Sep 30, 2023 | 119.76 Mn |
| Jun 30, 2023 | -25.57 Mn |
| Mar 31, 2023 | 20.52 Mn |
| Dec 31, 2022 | -1.15 Mn |
| Sep 30, 2022 | -8.91 Mn |
| Jun 30, 2022 | -6.47 Mn |
| Mar 31, 2022 | 46.27 Mn |
| Dec 31, 2021 | 19.74 Mn |
| Sep 30, 2021 | -17.75 Mn |